...
首页> 外文期刊>Gut and Liver >Endoscopic Mucosal Healing as a Treatment Target in Ulcerative Colitis: Does It Have the Same Role in Asian Patients?
【24h】

Endoscopic Mucosal Healing as a Treatment Target in Ulcerative Colitis: Does It Have the Same Role in Asian Patients?

机译:内镜粘膜愈合作为溃疡性结肠炎中的治疗靶标:它是否在亚洲患者中具有相同的作用?

获取原文
           

摘要

We read with great interest the article by Shin et al. , 1 which compared the outcomes of 131 ulcerative colitis (UC) patients in clinical remission according to the endoscopic mucosal healing status and the distribution pattern of mucosal inflammation. The au- thors reported that poor outcome-free survival was significantly higher in patients with endoscopic remission or only nonrectal inflammation than in those with rectal inflam- mation (p=0.003). Poor outcome-free survival in patients with only nonrectal inflam- mation was comparable to that in patients with endoscopic remission (p=0.647). In multivariable Cox regression analysis, rectal inflammation (hazard ratio, 5.76; p=0.027) was the only predictor of poor outcome. Therefore, the authors suggested that treat- ment escalation may be selectively required in consideration of the distribution pattern of residual mucosal inflammation in UC patients in clinical remission.
机译:我们对Shin等人的文章非常感兴趣。 1,其中131溃疡性结肠炎(UC)患者的结果与根据内镜粘膜愈合状态和粘膜炎症分布模式的临床缓解患者。 内镜下缓解患者或仅在直肠炎症的患者中,患者的患者患者患者的差异差异显着高(P = 0.003)。 患者患者的差异不良,仅与内镜缓解患者(P = 0.647)相当。 在多变量的Cox回归分析中,直肠炎症(危险比,5.76; p = 0.027)是差的结果的唯一预测因子。 因此,作者建议考虑临床缓解患者残留粘膜炎症的分布模式,可以选择性地需要选择性升级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号